OPCH
Option Care Health, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Option Care Health, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
No other changes.
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Annual filing, covered
10-K parsed · Feb 24 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 24 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
+6.45%
vs ±12.6% implied · ×0.51
shaded = implied · ▲▼ = realized
Tall tick = annual report · Source: EDGAR
News
Option Care Health, Inc.
31.79
+0.10 · +0.32%
post 31.79 0.00%
Same SIC code · 5
Same SEC industry code: BrightSpring Health Services, Inc., Chemed Corp, Addus HomeCare Corp and 2 more; of Option Care Health, Inc.'s 6 closest co-movers, 1 shares that code.
Same SIC code · 5
Same SEC industry code: BrightSpring Health Services, Inc., Chemed Corp, Addus HomeCare Corp and 2 more; of Option Care Health, Inc.'s 6 closest co-movers, 1 shares that code.
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $463.5M | 13.97% | +11.15% |
| Wellington | $247.1M | 7.44% | −0.97% |
| Vanguard Portfolioindex-like | $173.5M | 5.23% | +2.63% |
| Fuller & Thaler | $156.2M | 4.71% | +4.57% |
| Vanguardindex-like | $148.1M | 4.46% | +0.68% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $463.5M | 13.97% | +11.15% |
| Wellington | $247.1M | 7.44% | −0.97% |
| Vanguard Portfolioindex-like | $173.5M | 5.23% | +2.63% |
| Fuller & Thaler | $156.2M | 4.71% | +4.57% |
| Vanguardindex-like | $148.1M | 4.46% | +0.68% |
Expected move
No implied move.